Approval · Notice of Compliance 4644 · 1996
RISPERDAL: Notice of Compliance 4644
Issued April 4, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4644
- Date
- April 4, 1996
- Company
- Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for a once a day dosing regimen
- Therapeutic class
- Antipsychotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RISPERDAL | Not yet assigned | — |
Medicinal ingredients
- RISPERIDONE 1 MG per TAB
- RISPERIDONE 2 MG per TAB
- RISPERIDONE 4 MG per TAB